Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
670
NCT02771769
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2016
Completion: Jan 1, 2020
NCT05426668
"Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (hereinafter: immunotherapy) in NSCLC in Palliative Therapy"
Role: Collaborator
Start: Feb 28, 2025
Completion: Feb 29, 2028